SurModics Valuation
| SRDXDelisted Stock | USD 42.98 0.00 0.00% |
At this time, the company appears to be overvalued. SurModics has a current Real Value of $33.01 per share. The regular price of the company is $42.98. Our model measures the value of SurModics from inspecting the company fundamentals such as Shares Outstanding of 14.3 M, return on equity of -0.15, and Operating Margin of 0 % as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that SurModics' price fluctuation is very steady at this time. Calculation of the real value of SurModics is based on 3 months time horizon. Increasing SurModics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since SurModics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of SurModics Stock. However, SurModics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 42.98 | Real 33.01 | Hype 42.98 | Naive 40.43 |
The intrinsic value of SurModics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence SurModics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of SurModics helps investors to forecast how SurModics stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of SurModics more accurately as focusing exclusively on SurModics' fundamentals will not take into account other important factors: About SurModics Valuation
Our relative valuation model uses a comparative analysis of SurModics. We calculate exposure to SurModics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of SurModics's related companies.Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota. Surmodics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 389 people.
SurModics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 14.2 M | |
| Quarterly Earnings Growth Y O Y | 4.358 | |
| Forward Price Earnings | 208.3333 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Consideration for investing in SurModics Stock
If you are still planning to invest in SurModics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the SurModics' history and understand the potential risks before investing.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |